MANGALAM ORGANICS LIMITED (MANORG)

NSE: ₹470.35
BSE: ₹472.05
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication

Copies of the Newspaper Advertisement for IEPF Second 100 Days Campaign on Saksham Niveshak

2026-06-13 13:07:30
Announcement under Regulation 30 (LODR)-Investor Presentation

Investor Presentation for the quarter and year ended March, 2026.

2026-06-01 13:02:59
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper clippings regarding the extract of the Audited Standalone and Consolidated Financial results for the quarter and year ended March 31, 2026

2026-05-30 14:35:33
Financial Results For 31/03/2026

The Board of Directors at its meeting held today, i.e. May 29, 2026, has considered and approve the Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31, 2026 as reviewed and recommended by Audit committee along with the Auditor Report with unmodified opinion given by Statutory Auditors of the Company.

2026-05-29 16:45:21
Board Meeting Outcome for Outcome Of The Board Meeting Dated May 29, 2026

We hereby inform you that the Board of Directors of the Company, at its meeting held today i.e. Friday, May 29, 2026, inter alia, considered and approved the following: a) Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2026, as reviewed and recommended by the Audit Committee. b) Pursuant to Regulation 33(3)(d) of the Listing Regulations, we hereby declare that the Statutory Auditors of the Company, NGST & Associates, have issued the Audit Reports with an Unmodified opinion on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2026.

2026-05-29 16:35:55
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the year ended March, 2026

2026-05-26 17:39:27
Board Meeting Intimation for Intimation Of The Board Meeting Under Regulation 29 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’)

Pursuant to Regulation 29 of the SEBI Listing Regulations, we wish to inform you that a Meeting of the Board of Directors of the Company will be held on Friday, May 29, 2026 1. To consider and approve the Audited Standalone and Consolidated Financial Statements of the Company for the Quarter and Financial Year ended March 31, 2026 2. To consider any other business with the permission of the Chair

2026-05-25 12:25:25
Announcement Under Regulation 30 -Intimation Regarding A Second 100 Day Campaign – “Saksham Niveshak”

Shareholder communication pursuant to the Investor Education and Protection Fund Authority's (IEPFA) Second 100 Day Campaign on Saksham Niveshak

2026-05-22 16:54:29
Clarification On Price Movement In The Scrip Of Mangalam Organics Limited

With reference to the clarification sought by BSE, we hereby confirm that, as on date, there is no Unpublished Price Sensitive Information or any event/ information including any impending announcement which in our opinion may have a bearing on price/volume behaviour of the company's scrip.

2026-05-07 10:54:27

Quarterly Financials

Consolidated Standalone
Particulars Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Revenue from Operations 136.86 87.02 83.26 95.58 109.77 100.53 103.97 113.63 130.14 122.45 134.64 163.09
YOY Revenue Growth % -4.37% -28.66% -11.8% -2.76% -19.79% 15.52% 24.87% 18.88% 18.56% 21.8% 29.5% 43.53%
Other Income 0.49 0.47 0.68 0.53 0.66 0.46 0.39 5.50 21.96 1.18 -12.05 0.04
Total Income 137.35 87.49 83.94 96.12 110.43 100.98 104.36 119.13 152.10 123.63 122.59 163.14
Total Expenses + 136.76 86.65 82.34 94.28 108.44 97.20 101.28 110.88 146.05 122.13 117.16 156.76
Cost of Materials Consumed 57.98 59.90 48.88 68.48 92.02 84.07 55.13 74.51 93.18 77.22 108.96 117.94
Employee Benefit Expense 6.42 7.87 7.46 7.01 6.78 7.98 7.91 7.85 8.10 8.89 9.06 8.79
Other Expenses 14.66 18.05 8.69 2.58 13.63 26.08 21.12 20.85 19.47 17.31 29.40 23.96
Operating Profit 0.10 0.37 0.92 1.30 1.33 3.33 2.69 2.74 -15.91 0.31 17.48 6.33
OPM % 0.1% 0.4% 1.1% 1.4% 1.2% 3.3% 2.6% 2.4% -12.2% 0.3% 13% 3.9%
Profit Before Tax + 0.59 0.84 1.60 1.83 1.99 3.79 3.08 8.24 2.55 1.50 5.43 6.38
Tax Expense 0.27 0.17 -1.23 0.46 0.60 0.96 0.90 1.32 0.63 0.39 1.66 1.05
Tax % 45.8% 20.7% -77.2% 25.2% 30.4% 25.2% 29.4% 16% 24.9% 26.1% 30.5% 16.5%
Profit After Tax 0.32 0.67 2.83 1.37 1.38 2.83 2.17 6.92 1.91 1.11 3.77 5.32
EPS (Basic) 0.46 0.78 3.30 1.60 1.57 3.31 2.40 8.08 2.18 1.29 3.94 6.22

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 500.85 409.85 405.43 466.97 490.92 338.26
YOY Revenue Growth % 22.2% 1.09% -13.18% -4.88% 45.13% -
Other Income 16.59 2.04 2.49 1.39 1.44 1.05
Total Income 517.45 411.89 407.92 468.36 492.36 339.31
Total Expenses + 496.22 401.20 404.45 499.70 418.51 224.92
Cost of Materials Consumed 353.88 299.71 245.01 415.27 284.31 147.12
Employee Benefit Expense 33.91 29.68 26.72 22.70 29.63 26.91
Other Expenses 87.03 75.41 57.34 86.79 92.16 60.10
Operating Profit 4.63 8.64 0.99 -32.72 72.40 113.34
OPM % 0.9% 2.1% 0.2% -7% 14.7% 33.5%
Profit Before Exceptional 21.22 10.68 3.47 -31.33 73.85 114.39
Exceptional Items -3.51 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 17.72 10.68 3.47 -31.33 73.85 114.39
Tax Expense 4.00 2.92 -0.68 -5.93 19.55 29.42
Tax % 22.6% 27.4% -19.6% - 26.5% 25.7%
Profit After Tax 13.71 7.76 4.15 -25.40 54.29 84.97
EPS (Basic) 15.50 3.31 4.76 -29.51 63.32 98.92

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 256.33 302.96 245.88 236.29 204.14 121.11
Property, Plant & Equipment 240.28 222.78 214.08 204.68 180.98 120.58
Capital Work in Progress 0.00 0.00 0.39 0.00 7.66 0.00
Non-Current Investments 0.00 0.00 0.54 0.54 0.20 0.10
Goodwill 4.62 3.94 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 384.12 289.62 224.03 252.48 338.93 190.25
Inventories 273.34 202.73 119.67 171.68 242.86 106.13
Trade Receivables 72.19 55.19 74.25 57.60 43.95 34.44
Cash and Cash Equivalents 0.35 0.16 0.89 0.79 0.23 1.04
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 303.10 289.83 282.23 278.15 304.71 251.76
Equity Share Capital 8.56 8.56 8.56 8.56 8.56 8.56
Other Equity 294.54 281.26 273.66 269.59 296.15 243.20
Non-Current Liabilities 29.43 35.27 18.03 31.41 45.71 6.02
Current Liabilities 307.91 267.49 169.65 179.21 192.65 53.58
Total Liabilities 337.35 302.75 187.68 210.62 238.36 59.60

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities -20.20 -87.07 54.72 52.99 -84.63 26.40
Cash from Investing Activities -31.27 -29.65 -26.57 -31.66 -82.53 -28.25
Cash from Financing Activities 51.66 115.99 -28.05 -20.77 166.34 2.24
Net Increase/Decrease in Cash 0.19 -0.73 0.11 0.56 -0.82 0.40